StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Monday. The brokerage set a “hold” rating on the stock.

ObsEva Price Performance

The stock has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. ObsEva has a one year low of $0.08 and a one year high of $2.14. The business’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.04.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.